Richter posted clean EBIT of HUF 43.3bn (+20% YoY) on net sales HUF 192.9bn (+24% YoY) for Q2/22. Clean EBIT was slightly worse than the consensus estimate of HUF 44.3bn while net revenue beat consensus forecast of HUF 186bn. Clean EBIT margin stood at 22.5% compared to consensus estimate of 23.8% and 23.2% YoY. Richter booked milestone income in the amount of HUF 8.6bn in Q2/22 received from Abbvie for the the acceptance by the FDA for review of the sNDA request related to MDD indication of cariprazine. Clean net income came in at HUF 68.2bn, ahead of consensus estimate of HUF 60bn,driven by FX.
Chemical Works of Richter Gedeon is a multinational pharmaceutical company that is engaged in the research, development, production and marketing and trade of pharmaceutical products. Co.'s activities are divided into two major business segments: Pharmaceutical, including research, development and manufacturing of pharmaceutical products; and Wholesale and Retail including wholesale and retail trade through the distribution chain as well as marketing of its products. Co. is primarily engaged in production of gynecological, cardiovascular and gastroenterological products, antibiotics, antimicotics, OTC and medicines for treatment of the central nervous system.
Concorde Securities Ltd. is Hungary’s leading independent company engaged in investment banking activities. It provides its clients with integrated financial services, including securities trading, research, corporate financing advisory, capital market transactions, wealth management and investment advisory. The operational management of the company is the responsibility of the CEO, while the owners/managers (who control one-third of the company through their shares and options) are in charge of its strategic governance. Concorde Securities Ltd. is a member of the Budapest, Frankfurt, Warsaw and Bucharest stock exchanges, as well as of the Hungarian Association of Investment Service Providers.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.